| Literature DB >> 33626330 |
Marc Kschonsak1, Lionel Rougé2, Christopher P Arthur2, Ho Hoangdung2, Nidhi Patel2, Ingrid Kim3, Matthew C Johnson2, Edward Kraft4, Alexis L Rohou2, Avinash Gill3, Nadia Martinez-Martin5, Jian Payandeh6, Claudio Ciferri7.
Abstract
Human cytomegalovirus (HCMV) infects the majority of the human population and represents the leading viral cause of congenital birth defects. HCMV utilizes the glycoproteins gHgLgO (Trimer) to bind to platelet-derived growth factor receptor alpha (PDGFRα) and transforming growth factor beta receptor 3 (TGFβR3) to gain entry into multiple cell types. This complex is targeted by potent neutralizing antibodies and represents an important candidate for therapeutics against HCMV. Here, we determine three cryogenic electron microscopy (cryo-EM) structures of the trimer and the details of its interactions with four binding partners: the receptor proteins PDGFRα and TGFβR3 as well as two broadly neutralizing antibodies. Trimer binding to PDGFRα and TGFβR3 is mutually exclusive, suggesting that they function as independent entry receptors. In addition, Trimer-PDGFRα interaction has an inhibitory effect on PDGFRα signaling. Our results provide a framework for understanding HCMV receptor engagement, neutralization, and the development of anti-viral strategies against HCMV.Entities:
Keywords: HCMV entry; PDGFRα; TGFβR3; antibody neutralization; cryo-EM; trimer
Year: 2021 PMID: 33626330 DOI: 10.1016/j.cell.2021.01.036
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582